Characteristics of lysophosphatidylcholine-induced Ca2+ response in human neuroblastoma SH-SY5Y cells

Life Sciences

Volumn 80, Issue 9, 2007, Pages 886-892

  Li, Xiao Hua ^a,b   Wu, Yi Jun ^a  

^a INSTITUTE OF ZOOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Calcium influx; Demyelination; Endoplasmic reticulum Ca2+ store; Human neuroblastoma SH SY5Y cells; Lysophosphatidylcholine; Ryanodine receptors

Indexed keywords

2 AMINOETHOXYDIPHENYLBORANE; ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM ION; DIGITONIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL TRIPHOSPHATE RECEPTOR; LIPID; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHOLIPASE; PERTUSSIS TOXIN; PROCAINE; RECEPTOR; RUTHENIUM RED; RYANODINE RECEPTOR; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM ION; THAPSIGARGIN; UNCLASSIFIED DRUG; VERAPAMIL;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYTOSOL; DEMYELINATION; ENDOPLASMIC RETICULUM; EXTRACELLULAR CALCIUM; HUMAN; HUMAN CELL; HYDROLYSIS; NERVOUS SYSTEM; NEUROBLASTOMA CELL; NEUROTOXICITY;

CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM SIGNALING; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOPLASMIC RETICULUM; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; LYSOPHOSPHATIDYLCHOLINES; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SODIUM-CALCIUM EXCHANGER; VERAPAMIL;

EID: 33846452528     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.11.017     Document Type: Article

References (32)

1. Abou-Donia M.B., and Lapadula D.M. Mechanisms of organophosphorus ester-induced delayed neurotoxicity: type I and type II. Annual Review of Pharmacology and Toxicology 30 (1990) 405-440
2. Berlet H.H. Calcium-dependent neutral protease activity of myelin from bovine spinal cord: evidence for soluble cleavage products of myelin proteins. Neuroscience Letters 73 (1987) 266-270
3. Berridge M.J., Lipp P., and Bootman M.D. The versatility and universality of calcium signaling. Nature Reviews. Molecular Cell Biology 1 (2000) 11-21
4. Bouldin T.W., and Cavanagh J.B. Organophosphorous neuropathy. I. A teased-fiber study of the spatio-temporal spread of axonal degeneration. American Journal of Pathology 94 (1979) 241-252
5. Choudhary S., and Gill K.D. Protective effect of nimodipine on dichlorvos-induced delayed neurotoxicity in rat brain. Biochemical Pharmacology 62 (2001) 1265-1272
6. 2+ indicators with greatly improved fluorescence properties. Journal of Biological Chemistry 260 (1985) 3440-3450
7. Hall S.M. The effect of injections of lysophosphatidyl choline into white matter of the adult mouse spinal cord. Journal of Cell Science 10 (1972) 535-546
8. Iqbal K., Alonso Adel C., El-Akkad E., Gong C.X., Haque N., Khatoon S., Pei J.J., Tanimukai H., Tsujio I., Wang J.Z., and Grundke-Iqba I. Alzheimer neurofibrillary degeneration: therapeutic targets and high-throughput assays. Journal of Molecular Neuroscience 20 (2003) 425-429
9. Jean I., Allamargot C., Barthelaix-Pouplard A., and Fressinaud C. Axonal lesions and PDGF-enhanced remyelination in the rat corpus callosum after lysolecithin demyelination. NeuroReport 13 (2002) 627-631
10. Johnson M.K. The delayed neurotoxic effect of some organophosphorus compounds. Identification of the phosphorylation site as an esterase. Biochemical Journal 114 (1969) 711-717
11. + stimulated ATPase activity of rabbit and dog heart sarcolemma by lysophosphatidylcholine. Life Sciences 24 (1979) 1869-1875
12. Kostrzewa R.M., and Segura-Aguilar J. Novel mechanisms and approaches in the study of neurodegeneration and neuroprotection. A review. Neurotoxicity Research 5 (2003) 375-383
13. Mattson M.P., LaFerla F.M., Chan S.L., Leissring M.A., Shepel P.N., and Geiger J.D. Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends in Neurosciences 23 (2000) 222-229
14. Mohandas N., Wyatt J., Mel S.F., Rossi M.E., and Shohet S.B. Lipid translocation across the human erythrocyte membrane. Journal of Biological Chemistry 257 (1982) 6537-6543
15. 2+ system in HL-60 leukemia cells. The Biochemical Journal 336 (1998) 491-500
16. O'Neill S.C., Valdeolmillos M., and Eisner D.A. The effects of nickel on contraction and membrane current in isolated rat myocytes. Quarterly Journal of Experimental Physiology 73 (1988) 1017-1020
17. Quinn M.T., Parthasarathy S., and Steinberg D. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proceedings of the National Academy of Sciences of the United States of America 85 (1988) 2805-2809
18. Quistad G.B., and Casida J.E. Lysophospholipase inhibition by organophosphorus toxicants. Toxicology and Applied Pharmacology 196 (2004) 319-326
19. Quistad G.B., Barlow C., Winrow C.J., Sparks S.E., and Casida J.E. Evidence that mouse brain neuropathy target esterase is a lysophospholipase. Proceedings of the National Academy of Sciences of the United States of America 100 (2003) 7983-7987
20. Schlaepfer W.W. Neurofilaments: structure, metabolism and implication in disease. Journal of Neuropathology and Experimental Neurology 46 (1987) 117-129
21. Schlaepfer W.W., and Hasler M.B. Characterization of the calcium-induced disruption of neurofilaments in rat peripheral nerve. Brain Research 168 (1979) 299-309
22. 2+ accumulation in rat cardiac myocytes. American Journal of Physiology 244 (1983) H32-H38
23. Sedlis S.P., Hom M., Sequeira J.M., and Esposito R. Lysophosphatidylcholine accumulation in ischemic human myocardium. Journal of Laboratory and Clinical Medicine 121 (1993) 111-117
24. Smith K.J., and Hall S.M. Peripheral demyelination and remyelination initiated by the calcium-selective ionophore ionomycin: in vivo observations. Journal of Neurological Sciences 83 (1988) 37-53
25. Smith K.J., and Hall S.M. Central demyelination induced in vivo by the calcium ionophore ionomycin. Brain 117 (1994) 1351-1356
26. Suwita E., Lapadula D.M., and Abou-Donia M.B. Calcium and calmodulin stimulated in vitro phosphorylation of rooster brain tubulin and MAP-2 following a single oral dose of tri-o-cresyl phosphate. Brain Research 374 (1986) 199-203
27. Vidaver G.A., Ting A., and Lee J.W. Evidence that lysolecithin is an important causal agent of atherosclerosis. Journal of Theoretical Biology 115 (1985) 27-41
28. 2+ from a caffeine- and ryanodine-insensitive intracellular pool in rat atrial cells. Journal of Biological Chemistry 265 (1990) 6782-6787
29. Wang A., Deems R.A., and Dennis E.A. Cloning, expression, and catalytic mechanism of murine lysophospholipase I. Journal of Biological Chemistry 272 (1997) 12723-12729
30. Xu Y. Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction. Biochimica et Biophysica Acta 1582 (2002) 81-88
31. Yu L., Netticadan T., Xu Y.J., Panagia V., and Dhalla N.S. Mechanisms of lysophosphatidylcholine-induced increase in intracellular calcium in rat cardiomyocytes. Journal of Pharmacology and Experimental Therapeutics 286 (1998) 1-8
32. Yu Z., Luo H., Fu W., and Mattson M.P. The endoplasmic reticulum stress-responsive protein GRP78 protects neurons against excitotoxicity and apoptosis: suppression of oxidative stress and stabilization of calcium homeostasis. Experimental Neurology 155 (1999) 302-314